RETA
Reata Pharmaceuticals Inc
Chief Innovation Officer Colin John Meyer sold $53K of Reata Pharmaceuticals Inc
Sold$52,518
$84.57Price
621Shares
−1%Stake
What RETA did after the filing
- The stock from Wed, Mar 8 close, $83.96
- +18.9%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Apr 20 close.
Traded Tue, Mar 7. Filed Wed, Mar 8, 12:04 PM ET, during the session. Returns use the Mar 8 close and the Apr 20 close. Not investment advice.